{"title":"番荔枝叶氯仿部分生物活性成分的鉴定及其抗氧化活性和对与II型糖尿病相关的碳水化合物水解α-淀粉酶和α-葡萄糖苷酶活性的抑制作用:体外研究","authors":"O. Olasehinde, O. B. Afolabi","doi":"10.34172/jhp.2023.09","DOIUrl":null,"url":null,"abstract":"Introduction: Secondary metabolites from plants have been found to play an important role in the treatment of diabetes mellitus (DM) and its complications. Therefore, the purpose of this study was to identify the chemical components of Annona muricata leaf chloroform fraction (CFAm) and its in vitro antioxidant properties, as well as inhibitory activity against α-amylase and α-glucosidase enzymatic activities. Methods: Gas chromatography–mass spectrometry (GC-MS) technique was engaged in the identification of phytochemical constituents. Antioxidant activities such as DPPH free radical scavenging ability, reducing power capacity, hydroxyl radical scavenging ability, singlet oxygen scavenging capacity, as well as α-amylase and α-glucosidase inhibition were carried out using standard in vitro methods. Results: GC-MS analysis of CFAm revealed the presence of 23 phytochemicals, out of which 5 compounds had the highest % compositions (i.e., octadecanoic acid (20.35%), 2-propanone, 1-(4-hydroxy-3-methoxyphenyl) (12.04%), isocomene (22.60%), 9, 12, 15 octadecatrienoic acid, methyl ester (Z,Z,Z) (28. 98%), and quercetin, 5TMS derivative (18.28%)). Also, CFAm demonstrated a significant (P<0.05) inhibition against DPPH (IC50= 26.33±1.39 mg/mL), with OH free radical scavenging capacity (65.46 ± 1.39 mg/100 g), singlet oxygen scavenging capacity (55.24 ± 1.22 mg/100 g), and showed ferric reducing power (84.52 ± 2.84 mg/100 g). Also, CFAm exhibited a significant (P<0.05) inhibition against α-glucosidase (IC50= 71.06 ±1.45 mg/ mL) and α-amylase (IC50= 73.88±1.58 mg/mL) in a concentration-dependent manners. Conclusion: The remarkable properties demonstrated by CFAm, which are essential for the management of DM, could probably be credited to the presence of the various identified phytonutrients.","PeriodicalId":15934,"journal":{"name":"Journal of HerbMed Pharmacology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Identification of bioactive constituents of chloroform fraction from Annona muricata leaf, its antioxidant activity and inhibitory potential against carbohydrate-hydrolyzing α-amylase and α-glucosidase activities linked to type II diabetes mellitus: In vitro study\",\"authors\":\"O. Olasehinde, O. B. Afolabi\",\"doi\":\"10.34172/jhp.2023.09\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Secondary metabolites from plants have been found to play an important role in the treatment of diabetes mellitus (DM) and its complications. Therefore, the purpose of this study was to identify the chemical components of Annona muricata leaf chloroform fraction (CFAm) and its in vitro antioxidant properties, as well as inhibitory activity against α-amylase and α-glucosidase enzymatic activities. Methods: Gas chromatography–mass spectrometry (GC-MS) technique was engaged in the identification of phytochemical constituents. Antioxidant activities such as DPPH free radical scavenging ability, reducing power capacity, hydroxyl radical scavenging ability, singlet oxygen scavenging capacity, as well as α-amylase and α-glucosidase inhibition were carried out using standard in vitro methods. Results: GC-MS analysis of CFAm revealed the presence of 23 phytochemicals, out of which 5 compounds had the highest % compositions (i.e., octadecanoic acid (20.35%), 2-propanone, 1-(4-hydroxy-3-methoxyphenyl) (12.04%), isocomene (22.60%), 9, 12, 15 octadecatrienoic acid, methyl ester (Z,Z,Z) (28. 98%), and quercetin, 5TMS derivative (18.28%)). Also, CFAm demonstrated a significant (P<0.05) inhibition against DPPH (IC50= 26.33±1.39 mg/mL), with OH free radical scavenging capacity (65.46 ± 1.39 mg/100 g), singlet oxygen scavenging capacity (55.24 ± 1.22 mg/100 g), and showed ferric reducing power (84.52 ± 2.84 mg/100 g). Also, CFAm exhibited a significant (P<0.05) inhibition against α-glucosidase (IC50= 71.06 ±1.45 mg/ mL) and α-amylase (IC50= 73.88±1.58 mg/mL) in a concentration-dependent manners. Conclusion: The remarkable properties demonstrated by CFAm, which are essential for the management of DM, could probably be credited to the presence of the various identified phytonutrients.\",\"PeriodicalId\":15934,\"journal\":{\"name\":\"Journal of HerbMed Pharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of HerbMed Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/jhp.2023.09\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of HerbMed Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jhp.2023.09","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Identification of bioactive constituents of chloroform fraction from Annona muricata leaf, its antioxidant activity and inhibitory potential against carbohydrate-hydrolyzing α-amylase and α-glucosidase activities linked to type II diabetes mellitus: In vitro study
Introduction: Secondary metabolites from plants have been found to play an important role in the treatment of diabetes mellitus (DM) and its complications. Therefore, the purpose of this study was to identify the chemical components of Annona muricata leaf chloroform fraction (CFAm) and its in vitro antioxidant properties, as well as inhibitory activity against α-amylase and α-glucosidase enzymatic activities. Methods: Gas chromatography–mass spectrometry (GC-MS) technique was engaged in the identification of phytochemical constituents. Antioxidant activities such as DPPH free radical scavenging ability, reducing power capacity, hydroxyl radical scavenging ability, singlet oxygen scavenging capacity, as well as α-amylase and α-glucosidase inhibition were carried out using standard in vitro methods. Results: GC-MS analysis of CFAm revealed the presence of 23 phytochemicals, out of which 5 compounds had the highest % compositions (i.e., octadecanoic acid (20.35%), 2-propanone, 1-(4-hydroxy-3-methoxyphenyl) (12.04%), isocomene (22.60%), 9, 12, 15 octadecatrienoic acid, methyl ester (Z,Z,Z) (28. 98%), and quercetin, 5TMS derivative (18.28%)). Also, CFAm demonstrated a significant (P<0.05) inhibition against DPPH (IC50= 26.33±1.39 mg/mL), with OH free radical scavenging capacity (65.46 ± 1.39 mg/100 g), singlet oxygen scavenging capacity (55.24 ± 1.22 mg/100 g), and showed ferric reducing power (84.52 ± 2.84 mg/100 g). Also, CFAm exhibited a significant (P<0.05) inhibition against α-glucosidase (IC50= 71.06 ±1.45 mg/ mL) and α-amylase (IC50= 73.88±1.58 mg/mL) in a concentration-dependent manners. Conclusion: The remarkable properties demonstrated by CFAm, which are essential for the management of DM, could probably be credited to the presence of the various identified phytonutrients.
期刊介绍:
Journal of Herbmed Pharmacology (J Herbmed Pharmacol) is the intersection between medicinal plants and pharmacology. This international journal publishes manuscripts in the fields of medicinal plants, pharmacology and therapeutic. This journal aims to reach all relevant national and international medical institutions and persons in electronic version free of charge. J Herbmed Pharmacol has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of diseases. A further aim of this journal is to emphasize and strengthen the link between herbalists and pharmacologists. In addition, J Herbmed Pharmacol welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical pharmacology. Contributions in any of these formats are invited for editorial consideration following peer review by at least two experts in the field.